Skip to main content

Table 1 Clinical characteristics of patients' groups

From: Outcomes of bidirectional Glenn surgery done without prior cardiac catheterization

 

Non-catheterization group (n = 25)

Catheterization group (n = 68)

P value

Age, months

7 (3–12)

10.5 (5–23.5)

0.060

Weight, Kg

6 (4.8–8.7)

7.7 (6–9.9)

0.085

Follow-up period, months

18 (1.5–40)

32 (13–57)

0.025

Male/female, n (%)

15 (60)/10 (40)

41 (60.3)/27 (39.7)

0.980

Oxygen saturation, %

70 (55–75)

72 (68–77)

0.077

Diagnosis, n (%)

0.126

 HLHS/Variant

2 (8)

12 (17.6)

 

 Tricuspid atresia

9 (36)

10 (14.7)

 

 DILV

1 (4)

10 (14.7)

 

 Unbalanced AVSD

1 (4)

13 (19.1)

 

 DORV, non-committed VSD

6 (24)

11 (16.2)

 

 PA/IVS

2 (8)

4 (5.9)

 

 Others

4 (16)

8 (11.8)

 

Dominant ventricle

0.462

 RV dominance

4 (16)

17 (25)

 

 LV dominance

11 (44)

32 (47)

 

 Biventricular/indeterminate

10 (40)

19 (28)

 

Prior intervention, n (%)

0.002

 No prior intervention

21 (84)

21 (31)

 

 PDA stent

3 (12)

22 (32.4)

 

 Norwood

1 (4)

16 (32.5)

 

 MBTTS

0

3 (4.4)

 

 RVOT stent

0

1 (1.5)

 

 Pulmonary artery banding

0

5 (7.4)

 
  1. HLHS hypoplastic left heart syndrome, DILV Double inlet left ventricle, AVSD atrioventricular septal defect, DORV Double outlet right ventricle, VSD ventricular septal defect, PA/IVS pulmonary atresia with intact ventricular septum, PDA patent ductus arteriosus, MBTTS Modified Blalock–Taussig–Thomas shunt., RVOT right ventricle outflow tract